• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 3 filed by new insider Birmingham John Jacob

    10/16/25 4:15:10 PM ET
    $DRDB
    Get the next $DRDB alert in real time by email
    SEC FORM 3 SEC Form 3
    FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0104
    Estimated average burden
    hours per response: 0.5
    1. Name and Address of Reporting Person*
    Birmingham John Jacob

    (Last) (First) (Middle)
    C/O ROMAN DBDR ACQUISITION CORP. II
    9858 CLINT MOORE ROAD, SUITE 205

    (Street)
    BOCA RATON FL 33496

    (City) (State) (Zip)
    2. Date of Event Requiring Statement (Month/Day/Year)
    10/01/2025
    3. Issuer Name and Ticker or Trading Symbol
    Roman DBDR Acquisition Corp. II [ DRDB ]
    4. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    Chief Financial Officer
    5. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Beneficially Owned
    1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
    Table II - Derivative Securities Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
    Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    No securities are beneficially owned.
    /s/ John Jacob Birmingham 10/16/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $DRDB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DRDB

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $DRDB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Roman DBDR Acquisition Corp. II Announces Receipt of Nasdaq Deficiency Letter

    NEW YORK, Sept. 18, 2025 /PRNewswire/ -- Roman DBDR Acquisition Corp. II (the "Company") announced today that the Company received a deficiency letter (the "Deficiency Notice") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq"), notifying the Company that it was not in compliance with the requirements of Nasdaq Listing Rule 5250(c)(1) (the "Rule") as a result of not having filed with the U.S. Securities and Exchange Commission its Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2025 (the "Quarterly Report"). The Deficiency Notice has no immediate effect on the listing of the Company's securities on The Nasdaq Global Market. According t

    9/18/25 5:00:00 PM ET
    $DRDB

    $DRDB
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Roman DBDR Acquisition Corp. II

    SCHEDULE 13G/A - Roman DBDR Acquisition Corp. II (0002032528) (Subject)

    11/14/25 2:09:46 PM ET
    $DRDB

    SEC Form 10-Q filed by Roman DBDR Acquisition Corp. II

    10-Q - Roman DBDR Acquisition Corp. II (0002032528) (Filer)

    11/12/25 9:07:23 PM ET
    $DRDB

    SEC Form 10-Q filed by Roman DBDR Acquisition Corp. II

    10-Q - Roman DBDR Acquisition Corp. II (0002032528) (Filer)

    10/23/25 4:06:19 PM ET
    $DRDB

    $DRDB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Birmingham John Jacob

    3 - Roman DBDR Acquisition Corp. II (0002032528) (Issuer)

    10/16/25 4:15:10 PM ET
    $DRDB